Skip to main content

Advertisement

Table 1 Baseline characteristics in obese morbid patients with type 2 diabetes (DMbaseline) and prediabetes (preDMbaseline)

From: Cardiovascular risk reduction over time in patients with diabetes or pre-diabetes undergoing bariatric surgery: data from a single-center retrospective observational study

  DMbaseline (n = 48) preDMbaseline (n = 57)
Weight (kg) 131.8 (122.5, 145.5) 126 (115, 141)
BMI (kg/m2) 53.5 (47.2, 57.1) 49.6 (45.7, 54.2)
Body fat (%) 53.1 (46.9, 55.4) 52.3 (47.2, 55)
Waist (cm) 137.5 (126.7, 150.2) 133.5 (125.8, 145)
Fasting plasma glucose (mg/dl) 145 (110.5, 175.5) 103 (96, 110)
Plasma insulin (μU/ml) 22 (15, 38) 26.4 (18, 33.8)
C-peptide (ng/ml) 4.8 (3.8, 6.2) 5 (3.8, 5.7)
HOMA-IR 8.5 (4.9, 14.3) 6.7 (4.7, 8.8)
HbA1c (%) 7 (6.1, 8.3) 5.5 (5.3, 5.9)
Total Cholesterol (mg/dl) 204 (176, 234.5) 204 (186, 229)
LDL-c (mg/dl) 128.5 (100.8, 155.5) 134 (113, 145)
HDL-c (mg/dl) 44 (36, 48) 45 (38, 53)
Triglycerides (mg/dl) 164 (125, 238) 133 (120, 172)
SBP (mm Hg) 140 (130, 155) 136 (120, 152)
DBP (mm Hg) 90 (80, 96) 83 (75.3, 96.5)
Hypertension (%) 44 (91.7%) 42 (73.7%)
Dyslipidemia (%) 39 (81.3%) 27 (47.4%)
10-year CVD risk (FRS) (%) 20 (12, 30) 7 (3, 14)
  1. Data are shown as median and 1st and 3rd quartiles. SBP Systolic blood pressure, DBP Diastolic blood pressure, FRS Framingham Risk Score, LDL-c LDL cholesterol, HDL-c: HDL cholesterol